Acyclovir

NDC 72888-079 · Advagen Pharma Limited

Generic nameAcyclovir

Dosage formSUSPENSION

RouteORAL

Active ingredient(s)ACYCLOVIR

Strength200 mg/5mL

Pharmacologic classDNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]

Marketing categoryANDA

Packages

72888-079-17 — 473 mL in 1 BOTTLE (72888-079-17)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

72189-631 — Acyclovir, 72205-170 — Acyclovir, 72241-026 — Acyclovir, 72241-027 — Acyclovir, 72241-028 — Acyclovir, 72578-002 — acyclovir, 72578-082 — acyclovir, 72578-101 — Acyclovir, 72789-536 — acyclovir, 72789-587 — Acyclovir, 75834-122 — Acyclovir, 75834-123 — Acyclovir, 75834-124 — Acyclovir, 76420-050 — acyclovir, 76483-042 — Acyclovir, 76483-047 — Acyclovir, 80425-0270 — Acyclovir, 82804-005 — Acyclovir, 82804-012 — Acyclovir, 82804-245 — acyclovir, +172 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels